AbbVie Inc. Financial Report: Stocks & Senior Notes Overview 2025

The provided section of the financial report contains the following key information:

1. Company Information:

• Name: AbbVie Inc.
• Incorporation: Delaware (DE)
• Address: 1 North Waukegan Road, North Chicago, IL 60064-6400
• Phone: 847-932-7900
• CIK: 0001551152

2. Securities Information:

• Common Stock:
• • Par Value: $0.01
  • Ticker Symbol: ABBV
  • Exchange: NYSE (New York Stock Exchange)
• Senior Notes:
• • 0.750% Senior Notes due 2027 (Ticker: ABBV27, Exchange: NYSE)
  • 2.125% Senior Notes due 2028 (Ticker: ABBV28, Exchange: NYSE)
  • 2.625% Senior Notes due 2028 (Ticker: ABBV28B, Exchange: NYSE)
  • 2.125% Senior Notes due 2029 (Ticker: ABBV29, Exchange: NYSE)
  • 1.250% Senior Notes due 2031 (Ticker: ABBV31, Exchange: NYSE)

3. Filing Context:

• Filing Date: February 26, 2025
• Period End Date: February 26, 2025
• Reporting Units:
• • Currency: USD
  • Shares for Common Stock

4. Notes on Financial Reporting:

• The report utilizes XBRL (eXtensible Business Reporting Language) for structured data representation.
• It provides insights into different classes of stock and debt obligations the company has, which is critical for investors assessing AbbVie's capital structure and financial health.

This information highlights AbbVie Inc.'s stock and debt instruments, providing a basis for analyzing its investment opportunities and financial stability.